recent
west
african
ebola
viru
epidem
underscor
need
develop
novel
antiebola
therapeut
due
high
mortal
rate
ebola
viru
infect
lack
fdaapprov
vaccin
therapi
avail
prevent
treatment
tradit
chines
medicin
tcm
repres
huge
reservoir
bioactiv
chemic
mani
tcm
shown
antivir
activ
extract
tcm
evalu
use
high
throughput
assay
screen
inhibitor
ebola
viru
cell
entri
extract
rhodiola
rosea
display
specif
potent
inhibit
cell
entri
ebola
viru
marburg
viru
addit
twenti
commerci
compound
isol
rhodiola
rosea
evalu
use
pseudotyp
ebola
viru
entri
assay
found
ellag
acid
gallic
acid
two
structur
relat
compound
effect
one
activ
extract
two
pure
compound
valid
use
infecti
ebola
viru
timeofaddit
experi
suggest
mechanist
rhodiola
rosea
extract
effect
compound
act
earli
step
infect
cycl
follow
initi
cell
attach
prior
viralcel
membran
fusion
find
provid
evid
rhodiola
rosea
potent
antifiloviru
properti
may
develop
novel
antiebola
treatment
ebola
viru
ebov
marburg
viru
marv
belong
filovirida
famili
envelop
singlestrand
negativesens
rna
virus
filament
morpholog
infect
virus
caus
sever
hemorrhag
fever
human
nonhuman
primat
mortal
rate
recent
ebola
epidem
led
report
death
demonstr
urgent
medic
need
effect
antiebov
vaccin
therapeut
human
natur
product
consid
natur
combinatori
chemic
sourc
contain
structur
diversifi
bioactiv
chemic
thu
make
valuabl
reservoir
new
drug
discoveri
natur
product
direct
deriv
account
new
medicin
approv
us
food
drug
administr
fda
tradit
chines
medicin
tcm
mostli
deriv
natur
product
use
china
countriesregion
treat
variou
diseas
year
gain
popular
europ
north
america
complementari
altern
treatment
grow
number
tcm
proven
antivir
activ
low
toxic
herb
approv
china
food
drug
administr
treat
infect
virus
includ
influenza
viru
herp
simplex
viru
hepat
b
viru
enteroviru
respiratori
syncyti
viru
thu
tcm
repres
altern
sourc
identifi
novel
antivir
therapeut
identifi
new
drug
candid
tcm
previous
establish
high
throughput
screen
ht
platform
identifi
entri
inhibitor
highlypathogen
virus
screen
strategi
target
entri
virus
determin
glycoprotein
gp
virion
surfac
nativ
form
ebov
marv
gp
trimer
heterodim
respons
receptor
recognit
bind
mediat
viralhost
membran
fusion
endosom
interestingli
although
sequenc
ebov
marv
gp
quit
diverg
share
mani
conserv
featur
receptor
recognit
membran
fusion
indic
possibl
develop
broad
spectrum
antivir
virus
exampl
ebov
marv
gp
recogn
attach
factor
like
glycosaminoglycan
ctype
lectin
etc
use
macropinocytosi
intern
virion
traffick
endosomallysosom
system
gp
cleav
cystein
proteas
cathepsin
b
l
expos
region
gp
bind
niemannpick
intern
ebovmarv
receptor
interact
necessari
fusion
viru
membran
host
endosom
membran
late
endosomelysosom
releas
capsid
cell
cytoplasm
initi
genom
replic
recent
compound
identifi
target
ebovgp
mediat
viru
entri
make
promis
target
drug
develop
howev
none
promis
lead
develop
treatment
given
mani
lead
make
past
clinic
advanc
addit
treatment
candid
still
need
report
evalu
tcm
extract
demonstr
extract
rhodiola
rosea
two
isol
chemic
relat
compound
effect
inhibit
ebola
viru
entri
find
import
implic
explor
develop
tcm
potenti
antivir
ebola
marburg
viral
infect
human
lung
epitheli
cell
line
human
embryon
kidney
cell
line
hela
cell
line
cultur
dmem
cellgro
manassa
va
usa
supplement
fetal
bovin
serum
fb
gibco
carlsbad
ca
usa
streptomycin
unit
penicillin
invitrogen
carlsbad
ca
usa
c
co
hivmarv
hivebov
pseudovirion
produc
transient
cotransfect
correspond
gp
encod
plasmid
influenza
ahemagglutinin
ha
neuraminidas
na
strain
strain
marburgvirusgp
ebolaviru
zairegp
hiv
core
plasmid
e
cell
use
polyethylenimin
base
transfect
protocol
cell
wash
phosphatebuff
salin
pb
h
transfect
ml
fresh
media
ad
falcon
mm
tctreat
cell
cultur
dish
supernat
collect
filter
pore
size
filter
nalgen
rochest
ny
usa
h
posttransfect
pseudovirion
stock
store
c
prior
use
pseudovirus
activ
tpcktrypsin
infect
cell
one
hundr
twentyeight
tradit
chines
herb
purchas
chines
herbal
medicin
market
china
extract
prepar
plant
use
extract
method
includ
aqueou
extract
organicsolv
extract
dri
vacuum
c
dissolv
dmso
extract
array
plate
mgml
stock
concentr
solvent
sampl
plate
store
c
use
twenti
chemic
compon
puriti
r
rosea
purchas
nation
institut
food
drug
control
jinan
china
tcm
extract
librari
screen
plate
final
concentr
dmso
vv
lowpassag
cell
seed
plate
densiti
cellswel
h
infect
presenc
tcm
extract
cell
challeng
hivebov
pseudotyp
virion
janu
robot
workstat
perkinelm
waltham
usa
infect
quantifi
h
incub
measur
luciferas
activ
neolit
report
gene
assay
system
perkinelm
data
normal
signal
neg
control
viru
alon
dmso
averag
inhibit
duplic
appli
pick
hit
select
activ
extract
reformat
new
plate
test
hivebov
hivmarv
dmso
vv
confirm
primari
result
cell
cytotox
examin
h
post
treatment
use
celltiterglo
luminesc
cell
viabil
assay
promega
madison
wi
usa
treat
antivir
screen
hit
extract
twofold
serial
dilut
doserespons
titrat
ic
cc
valu
determin
fit
doserespons
curv
fourparamet
logist
regress
data
graphpad
prism
softwar
version
la
jolla
ca
usa
hivebov
virion
incub
cell
c
h
viru
remov
cell
wash
ice
cold
pb
twice
fresh
media
ad
viru
entri
initi
shift
temperatur
c
differ
time
point
viru
entri
r
rosea
extract
gallic
acid
ellag
acid
benztropin
santa
cruz
biotech
dalla
tx
usa
heparin
sigmaaldrich
st
loui
mo
usa
zidovudin
sigmaaldrich
tocri
bioscienc
bristol
uk
drug
vehicl
dmso
introduc
assess
impact
viru
entri
triplic
well
treatment
time
point
viru
infect
quantifi
h
post
infect
describ
experi
use
recombin
infecti
zair
ebola
viru
perform
biosafeti
level
facil
texa
biomed
research
institut
infecti
ebov
marv
produc
accord
previous
describ
method
zair
ebov
mayinga
strain
assay
kind
gift
heinz
feldmann
nih
rocki
mountain
laboratori
hamilton
mt
usa
insert
green
fluoresc
protein
gfp
nucleoprotein
np
viru
grown
vero
cell
viru
clarifi
supernat
pellet
sucros
cushion
centrifug
g
h
c
viru
pellet
suspend
pb
store
aliquot
c
use
infect
assay
hela
cell
per
well
grown
overnight
tissu
cultur
plate
dmem
cultur
medium
supplement
fb
cell
infect
ebovgfp
viru
moi
presenc
tcm
extract
effect
compound
variou
concentr
bafilomycin
final
concentr
nm
use
posit
control
treatment
treatment
done
duplic
h
incub
postinfect
cell
fix
immers
plate
formalin
h
c
fix
plate
inactiv
use
formalin
brought
formalin
decant
plate
wash
twice
pb
cell
nuclei
stain
use
hoechst
dilut
plate
imag
nuclei
blue
infect
cell
express
gfp
green
count
use
cellprofil
softwar
version
broad
institut
cambridg
usa
total
number
nuclei
blue
use
check
cell
function
reduct
indic
growth
arrest
toxic
note
analysi
natur
product
includ
tradit
chines
medicin
tcm
repres
rich
sourc
structur
diversifi
bioactiv
compound
drug
discoveri
find
potenti
antivir
tcm
first
made
librari
crude
extract
tcm
aqueou
extract
organicsolv
extract
previous
establish
cellbas
ht
platform
perform
compar
screen
librari
three
pseudotyp
virus
identifi
entri
inhibitor
tcm
extract
librari
screen
final
concentr
infect
hivebov
pseudovirion
cell
one
ebov
specif
hit
identifi
show
inhibit
hivebov
infect
inhibit
infect
pseudovirion
figur
extract
rhodiola
rosea
evalu
cell
toxic
antivir
activ
hivebov
hivmarv
pseudovirion
extract
exhibit
specif
antivir
activ
pseudotyp
ebov
marv
entri
littl
inhibitori
activ
entri
two
pseudotyp
influenza
viru
subtyp
figur
indic
tcm
plant
r
rosea
broad
activ
distantli
relat
filovirus
chines
medicin
tcm
extract
librari
extract
tcm
screen
pseudoypt
ebov
virus
final
concentr
r
rosea
extract
show
inhibit
ebov
inhibitioin
pseudovirion
b
r
rosea
extract
valid
variou
pseudovirion
includ
ebov
marv
final
concentr
data
mean
sd
three
independ
experi
p
ebov
marv
compar
group
p
ebov
marv
compar
group
sinc
differ
extract
method
greatli
influenc
composit
concentr
effect
bioactiv
molecul
extract
compar
antifiloviru
activ
six
differ
extract
r
rosea
variou
extract
method
tabl
six
extract
test
cell
pseudotyp
ebov
marv
infect
extract
show
strong
antivir
activ
virus
figur
extract
ethanol
ultrason
extract
show
best
antivir
activ
inhibit
hivebov
inhibit
hivmarv
respect
extract
evalu
titrat
pseudotyp
filovirus
demonstr
inhibitori
concentr
ic
valu
ebov
pseudovirion
ic
valu
marv
pseudovirion
respect
figur
cytotox
extract
low
give
cytotox
concentr
cc
valu
figur
select
index
si
extract
ebov
marv
pseudovirion
thu
make
attract
candid
antifiloviru
evalu
develop
water
decoct
follow
ethanol
precipit
chemic
composit
r
rosea
extens
studi
differ
chemic
fraction
avail
includ
salirosid
aglycon
tyrosol
cinnam
glycosid
flavonoid
tannin
gallic
acid
well
essenti
oil
twenti
commerci
avail
fraction
test
hivebov
infect
cell
ellag
acid
gallic
acid
activ
pseudotyp
virion
entri
ebov
entri
respect
less
activ
compon
includ
quercetin
ursol
acid
rosmarin
acid
inhibit
viru
entri
figur
tabl
ellag
acid
gallic
acid
character
show
typic
sshape
doserespons
inhibit
infect
filovir
pseudovirion
ellag
acid
ic
valu
ebov
marv
pseudovirion
respect
figur
gallic
acid
show
approxim
fourfold
lesser
activ
pseudovirion
figur
compound
display
neglig
toxic
effect
cell
cc
ellag
acid
gallic
acid
respect
figur
result
suggest
ellag
acid
gallic
acid
like
major
activ
compon
contribut
antifilovir
activ
r
rosea
valid
antifiloviru
activ
r
rosea
extract
activ
compon
r
rosea
extract
ethanol
ultrason
extract
ellag
gallic
acid
evalu
hela
cell
infecti
ebov
infect
facil
shown
figur
b
r
rosea
extract
ellag
acid
gallic
acid
display
good
inhibit
infecti
ebov
hela
cell
r
rosea
extract
show
ic
valu
ellag
acid
gallic
acid
show
ic
valu
respect
cell
toxic
r
rosea
extract
ellag
acid
gallic
acid
also
evalu
hela
cell
cc
select
indic
respect
antivir
activ
also
examin
infecti
marv
hela
cell
r
rosea
extract
inhibit
highest
concentr
test
supplementari
materi
figur
result
demonstr
r
rosea
extract
ellag
acid
gallic
acid
effect
block
infect
ebov
less
effect
marv
investig
entri
stage
r
rosea
extract
activ
compon
exert
antivir
activ
timeofaddit
experi
previous
describ
perform
hivebov
pseudovirion
presenc
r
rosea
extract
ellag
acid
gallic
acid
sever
control
compound
hivebov
virion
allow
attach
cell
c
unattach
viru
wash
free
cell
uptak
viru
initi
shift
incub
temperatur
c
tcm
extract
compound
introduc
variou
time
point
evalu
antivir
effect
shown
figur
heparin
exhibit
best
antivir
effect
time
point
h
quickli
lost
activ
viru
entri
start
indic
block
viru
attach
cell
surfac
zidovudin
remain
activ
late
phase
viru
entri
target
hiv
revers
transcript
event
follow
viralendosom
fusion
r
rosea
extract
show
similar
trend
cathepsin
b
inhibitor
heparin
zidovudin
suggest
may
act
site
cathepsin
b
inhibitor
endosom
r
rosea
extract
two
activ
compon
also
evalu
benztropin
benztropin
start
lose
inhibitori
effect
ad
h
post
entri
beyond
consist
report
inhibit
ebovgp
mediat
fusion
r
rosea
extract
ellag
gallic
acid
show
similar
time
loss
antivir
activ
trend
benztropin
indic
may
act
similar
postattach
step
benztropin
block
infect
ebov
prior
viralendosom
membran
fusion
figur
studi
evalu
sever
hundr
extract
tradit
chines
medicin
tcm
effort
identifi
potenti
antivir
agent
filovirus
emerg
viral
pathogen
show
extract
plant
rhodiola
rosea
l
specif
inhibit
entri
infect
ebola
marburg
virus
identifi
two
chemic
relat
compound
gallic
acid
ellag
acid
isol
r
rosea
commerci
avail
effect
block
entri
ebola
viru
lesser
extent
marburg
viru
find
demonstr
r
rosea
like
tcm
strong
antiebov
activ
explor
develop
potenti
antivir
sinc
glycoprotein
gp
ebola
marburg
viru
viral
surfac
protein
respons
bind
surfac
receptor
mediat
fusion
viralcel
membran
endosom
compart
consid
good
antifilovir
target
inde
gp
major
target
develop
prophylact
therapeut
antiebola
vaccin
sever
potenti
vaccin
shown
highli
effect
protect
anim
small
anim
nonhuman
primat
lethal
ebola
viru
infect
demonstr
gp
excel
antivir
target
similarli
sever
small
molecul
entri
inhibitor
ebola
viru
report
includ
nonspecif
cathepsin
inhibitor
specif
cathepsin
bl
inhibitor
compound
target
gp
interact
recent
gpcr
antagonist
particularli
antihistaminelik
inhibitor
howev
whether
small
molecul
entri
inhibitor
protect
anim
model
lethal
ebola
viru
infect
known
yet
therefor
imper
explor
identifi
novel
small
molecul
potent
entri
inhibitor
potenti
antivir
contrast
synthet
small
molecul
tcm
natur
product
better
coverag
biolog
relev
chemic
space
like
reach
intracellular
site
action
fact
natur
product
includ
tcm
one
import
sourc
discoveri
develop
new
drug
mani
plantderiv
compound
report
antivir
effect
investig
antivir
efficaci
anim
studi
human
clinic
trial
approxim
approv
antivir
small
molecul
drug
origin
deriv
botan
natur
product
deriv
current
studi
focus
evalu
tcm
identifi
potenti
antiebola
agent
use
cellbas
screen
highthroughput
protocol
develop
us
show
r
rosea
extract
effect
antifilovir
agent
particularli
ebola
viru
r
rosea
extract
ic
valu
pseudoviru
infect
assay
ic
valu
infecti
ebov
infect
assay
respect
inhibit
marburg
viru
ic
valu
pseudoviru
assay
ic
valu
infecti
viru
assay
respect
figur
antiebov
activ
r
rosea
better
ic
best
report
tcm
prunella
vulgari
extract
far
r
rosea
extens
character
chemic
identifi
roughli
polar
compound
isol
water
alcohol
extract
includ
glycosid
organ
acid
phenol
show
two
chemic
relat
compound
ellag
acid
gallic
acid
effect
inhibitor
among
test
compound
isol
r
rosea
figur
addit
quercetin
ursol
acid
rosmarin
acid
also
exhibit
mild
inhibit
pseudotyp
ebov
entri
studi
compon
r
rosea
salidrosid
tyrosol
show
antiebov
activ
figur
ellag
acid
show
roughli
twofold
better
antifiloviru
activ
gallic
acid
infecti
recombin
ebov
infect
ic
valu
respect
figur
consid
ic
ellag
gallic
acid
much
lower
r
rosea
extract
conclud
compon
compound
extract
involv
block
ebola
viru
entri
addit
synergist
manner
ellag
acid
gallic
acid
addit
much
less
antimarv
activ
acid
r
rosea
extract
also
suggest
compon
may
target
glycoprotein
virusspecif
way
r
rosea
fraction
studi
need
identifi
character
compon
mechanist
extract
r
rosea
ellag
acid
gallic
acid
block
ebola
viru
entri
clear
present
gallic
acid
report
inhibit
entri
human
rhinovirus
herp
simplex
viru
type
viru
prevent
virion
attach
cell
surfac
howev
unlik
underli
inhibitori
mechan
ebola
viru
studi
figur
show
unlik
heparin
block
filoviru
attach
cell
surfac
introduc
gallic
acid
r
rosea
extract
ebov
bind
cell
surfac
time
point
h
still
strongli
inhibit
ebov
entri
suggest
bind
step
primari
target
gallic
acid
r
rosea
extract
timeofaddit
experi
suggest
inhibitor
act
similar
postbind
step
endosom
cathepsin
b
inhibitor
previous
character
entri
inhibitor
benztropin
bind
ebovgp
protein
interfer
gpmediat
fusion
endosom
delic
experi
requir
confirm
find
pinpoint
exact
entri
step
drug
target
anoth
possibl
compound
r
rosea
target
endosom
calcium
channel
call
two
pore
channel
tpc
like
tetrandin
biobenzylisoquinolin
alkaloid
isol
tcm
plant
stephania
tetrandra
find
provid
impetu
explor
tcm
natur
product
potenti
antivir
ebola
viru
virus
tcm
econom
access
easier
store
distribut
therapi
preclin
data
includ
recombin
vesicular
stomat
virusvectoredchimpanze
adenoviru
type
ebolaviru
vaccin
expens
monoclon
antibodi
cocktail
zmapp
repres
uniqu
treatment
option
peopl
resourceconstrain
africa
ebola
viru
outbreak
occur
often
tcm
obtain
cheapli
fast
could
use
complementari
treatment
vaccineantibodi
base
strategi
immedi
avail
conclus
identifi
r
rosea
potent
ebov
entri
agent
tcm
potent
antiebola
activ
proven
safeti
profil
make
promis
antivir
develop
though
gallic
ellag
acid
identifi
activ
compon
detail
fraction
chemic
research
need
purifi
activ
ingredi
elucid
chemic
act
synerg
inhibit
filoviru
entri
supplementari
materi
follow
avail
onlin
http
figur
antifiloviru
activ
r
rosea
extract
ellag
acid
gallic
acid
infecti
marv
entri
tabl
ic
cc
valu
confid
interv
ci
select
indic
si
figur
